MedPath

Comparison between 0.25% bupivacaine and 0.375% ropivacaine in tranversus abdominis plane block for pain relief after total laproscopic hysterectomy operatio

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/06/054000
Lead Sponsor
Gujarat Adani Institute Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Female patients of age beetween 18-60 years undergoing total laparoscopic hysterectomy.

2) Patient With ASA grade: I and II.

Exclusion Criteria

1) patients not willing to participate in study.

2) Patients with coagulation abnormalities.

3) Patient with Local site skin infection.

4) Patients having hypersensitive reaction to any of the drugs being used.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath